Free tool
Drug Trial Radar: Dermatology
Last checked: Nov 20, 2026Latest source record: Jan 21, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
2
Active, not recruiting, industry sponsors, Dermatology, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
2 trials
Showing 1 to 2, recently updated first.
- A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne PatientsActive, not recruiting
Sun Pharmaceutical Industries LimitedIndustry
NCT06425900 · 10 participants · Start Jul 1, 2024 · Primary completion Mar 2026
Drug: Winlevi (Clascoterone) cream 1% · For: Acne Vulgaris
Sites: High Point, North Carolina
- A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or ScalpPivotal-lookingActive, not recruiting
Almirall, S.A.Industry
NCT05387525 · 447 participants · Start Oct 24, 2022 · Primary completion Jul 2027
Drug: Tirbanibulin (Klisyri®) 10 mg/g ointment; Diclofenac Sodium 3% Gel · For: Keratosis, Actinic
Sites: Lille, France; Marseille, France; Nice, France · 49 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.